乐心医疗
(300562)
| 流通市值：22.50亿 | | | 总市值：30.19亿 |
| 流通股本：1.63亿 | | | 总股本：2.19亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 197,732,623.77 | 702,594,496.51 | 501,394,898.07 | 736,268,365.09 |
| 交易性金融资产 | 542,772,698.05 | 3,145,941.55 | 208,957,541.64 | 187,497.25 |
| 应收票据及应收账款 | 177,852,603.64 | 166,794,362.95 | 175,475,185.71 | 202,996,148.86 |
| 应收账款 | 177,852,603.64 | 166,794,362.95 | 175,475,185.71 | 202,996,148.86 |
| 应收款项融资 | 537,501.11 | 252,026.88 | 1,163,203.64 | 4,284,754.81 |
| 预付款项 | 3,165,892.73 | 2,290,414.82 | 4,188,891.51 | 5,241,194.21 |
| 其他应收款合计 | 3,953,541.79 | 9,513,427.85 | 3,994,190.7 | 4,177,438.94 |
| 存货 | 57,676,734.38 | 76,849,916.26 | 66,629,867.62 | 70,863,383.74 |
| 其他流动资产 | 12,293,468.12 | 14,952,231.34 | 13,310,105.83 | 7,189,989.97 |
| 流动资产合计 | 995,985,063.59 | 976,392,818.16 | 975,113,884.72 | 1,031,208,772.87 |
| 非流动资产: | | | | |
| 长期股权投资 | 3,902,237.42 | 4,831,343.67 | 7,096,293.02 | 7,756,732.91 |
| 其他权益工具投资 | 76,080,099.49 | 76,881,383.27 | 94,129,440.62 | 94,372,859.42 |
| 其他非流动金融资产 | 16,292,903 | 14,287,316 | 12,101,746 | 12,203,426 |
| 投资性房地产 | 13,297,499.13 | 13,421,673.14 | 13,545,847.14 | 13,670,021.14 |
| 固定资产 | 210,820,422.92 | 210,551,948.26 | 203,314,357.59 | 205,808,615.45 |
| 在建工程 | 8,182,055.96 | 7,958,825.27 | 17,978,119.34 | 17,844,302.35 |
| 使用权资产 | 2,790,250.5 | 3,723,102.1 | 5,117,836.92 | 6,029,559.57 |
| 无形资产 | 54,501,649 | 56,404,561.18 | 58,438,522.96 | 60,240,279.74 |
| 商誉 | - | - | 9,047,634.19 | 9,047,634.19 |
| 长期待摊费用 | 7,541,192.08 | 8,479,382.4 | 9,443,628.75 | 10,425,641.5 |
| 递延所得税资产 | 17,685,241.91 | 17,992,734.27 | 14,401,285.46 | 13,974,285.8 |
| 其他非流动资产 | 462,500 | 462,500 | - | - |
| 非流动资产合计 | 411,556,051.41 | 414,994,769.56 | 444,614,711.99 | 451,373,358.07 |
| 资产总计 | 1,407,541,115 | 1,391,387,587.72 | 1,419,728,596.71 | 1,482,582,130.94 |
| 流动负债: | | | | |
| 短期借款 | 47,000,000 | 47,000,000 | 89,610,381.86 | 141,655,464.91 |
| 交易性金融负债 | 2,576,816.56 | 3,132,392.74 | - | - |
| 应付票据及应付账款 | 216,451,353.79 | 234,959,898.08 | 237,174,364.61 | 242,919,158.68 |
| 其中：应付票据 | 143,190,388.2 | 138,494,342.47 | 145,825,065.93 | 141,785,380.94 |
| 应付账款 | 73,260,965.59 | 96,465,555.61 | 91,349,298.68 | 101,133,777.74 |
| 合同负债 | 28,242,001.54 | 32,366,644.67 | 22,302,868.04 | 27,592,878.02 |
| 应付职工薪酬 | 25,124,046.31 | 24,897,339.24 | 25,295,218.23 | 25,960,065.68 |
| 应交税费 | 2,618,586.44 | 4,387,901.72 | 4,006,220.08 | 3,768,290.4 |
| 其他应付款合计 | 26,966,168.02 | 22,356,885.06 | 27,797,030.89 | 29,926,226.22 |
| 应付股利 | - | - | 609,382.5 | 474,182.5 |
| 一年内到期的非流动负债 | 2,438,289.66 | 3,419,879.06 | 3,970,864.76 | 5,235,178.79 |
| 其他流动负债 | 574,715.76 | 356,932.4 | 415,617.19 | 382,034.36 |
| 流动负债合计 | 351,991,978.08 | 372,877,872.97 | 410,572,565.66 | 477,439,297.06 |
| 非流动负债: | | | | |
| 租赁负债 | - | 260,810 | 1,576,012.95 | 1,576,639.99 |
| 预计负债 | 1,550,000 | 1,550,000 | - | - |
| 递延收益 | 10,180,869.79 | 10,369,790.37 | 10,023,194.65 | 10,190,423.23 |
| 递延所得税负债 | 3,250,879.23 | 3,297,432.22 | 5,141,923.75 | 4,577,812.94 |
| 非流动负债合计 | 14,981,749.02 | 15,478,032.59 | 16,741,131.35 | 16,344,876.16 |
| 负债合计 | 366,973,727.1 | 388,355,905.56 | 427,313,697.01 | 493,784,173.22 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 218,573,688 | 217,751,188 | 217,791,188 | 217,466,188 |
| 资本公积 | 541,268,195.13 | 536,440,411.82 | 537,322,367.21 | 534,550,792.22 |
| 减:库存股 | - | - | 7,928,068.93 | 13,096,868.93 |
| 其他综合收益 | -29,953,325.36 | -29,946,693.42 | -18,002,432.07 | -18,090,798.45 |
| 盈余公积 | 56,977,405.51 | 56,977,405.51 | 54,047,722.03 | 54,047,722.03 |
| 未分配利润 | 275,272,495.38 | 243,198,687.07 | 229,762,354.73 | 234,619,069.41 |
| 归属于母公司股东权益合计 | 1,062,138,458.66 | 1,024,420,998.98 | 1,012,993,130.97 | 1,009,496,104.28 |
| 少数股东权益 | -21,571,070.76 | -21,389,316.82 | -20,578,231.27 | -20,698,146.56 |
| 股东权益合计 | 1,040,567,387.9 | 1,003,031,682.16 | 992,414,899.7 | 988,797,957.72 |
| 负债和股东权益合计 | 1,407,541,115 | 1,391,387,587.72 | 1,419,728,596.71 | 1,482,582,130.94 |
| 公告日期 | 2026-04-24 | 2026-04-10 | 2025-10-28 | 2025-08-16 |
| 审计意见(境内) | | 标准无保留意见 | | |